Large Fraction Radiation Therapy Combined With Lenalidomide, and Glofitamab in Refractory Relapsed DLBCL

Abroad (travel likely)RecruitingPHASE2

Conditions

Diffuse Large B-cell Lymphoma · Relapsed and Refractory

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Contact: Study coordinator (Zhijuan Lin, Dr) · zjuan_lin@126.com · 15960283462

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Real-World Study of DLBCL With Different Genetic Subtypes

DLBCL - Diffuse Large B Cell Lymphoma · Lymphoma

Abroad (travel likely)Recruiting

Shanghai, China

Nemtabrutinib and Pembrolizumab for the Treatment of Richter Transformation, Diffuse Large B-cell Lymphoma Subtype

Richter Syndrome · Diffuse Large B-Cell Lymphoma · Chronic Lymphocytic Leukemia

Abroad (travel likely)RecruitingPHASE2

Buffalo, United States

Golcadomide Post-CAR T-cell in R/R Aggressive Large B-cell Lymphoma Patients With High Risk of Relapse

Diffuse Large B-cell Lymphoma Refractory · Refractory Primary Mediastinal Large B-Cell Lymphoma · Refractory Transformed B-cell Non-Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Créteil, France · Dijon, France

R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse

Diffuse Large B-cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Shanghai, China · Ürümqi, China